Martin Pellinat joined Health 2.0 to demo VTOC, VisionTree’s web-based patient-centered health record management, communication and data collection system. VTOC, as shown in the demo, delivers quality patient and provider communication and documentation through a system that meets patient safety and risk guidelines while also reducing transcription costs.

The 5 tools in this breakout continued to add fire to the empowered patient movement. By enabling consumer data access at the tip of your fingers, the technology demonstrations highlighted here showcased the varied and encompassing ways we can all better understand and act on our health.

Martin Pellinat, CEO, VisionTree Software Inc.

VisionTree is the leading company working in patient portal technology. Martin comes to us to demonstrate how patients can contact doctors directly through an online messaging system, booking appointments and receiving consultations online.

We’ll take a look physician adoption of clinical groupware, including online encounters and patient communication, and examine what type of technology use will qualify as part of “meaningful use.” Moderated by: Julie Murchinson from Health 2.0 Accelerator, and featuring Howard Steinberg (Chief Executive Officer, dLife), Ellen Badinelli (Chief Enthusiast and Owner, ScanAvert), Alexandra Drane (President, Eliza), Mike Kirkwood (Chief Executive Officer, Polka), Erick Von Schweber (Executive Co-Chair, SurveyorHEALTH), and Matt Parker (Vice President, DestinationRx).

 Martin Pellinat, VisionTree Software

VisionTree was founded with the goal of patient-centric technology. Martin demonstrates how easy VisionTree is to use both as a physician and a consumer, for one-stop access to patient files and backgrounds.

Martin Pellinat, Chief Executive Officer and Founder, VisionTree Systems

VisionTree is filling in the cracks of health care communications. They’re replacing paper in the communications between patients and doctors in teaching hospitals across the nation, managing multi-site and multi-national clinical trials, and allowing doctors to manage their referral networks. Martin founded the company but you might still bump into him if you make a random visit to UCSF or UCLA.